Taisho To Go Private To Aid 'Dynamic' Restructuring, R&D Investment

$4.8bn MBO Japan's Largest

By privatizing the firm, Taisho aims to implement several measures that would upset the firm's finance for an instant.
Taisho aims to progress business, R&D through take-private move • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Japan

More from Focus On Asia